Vytisknout
0442392 - ÚMG 2015 RIV DE eng J - Článek v odborném periodiku
Bruhl, H. - Cihak, J. - Talke, Y. - Rodriguez-Gomez, M. - Hermann, F. - Goebel, N. - Renner, K. - Plachý, Jiří - Stangassinger, M. - Archemann, S. - Nimmerjahn, F. - Mack, M.
B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis.
European Journal of Immunology. Roč. 45, č. 3 (2015), s. 705-715. ISSN 0014-2980. E-ISSN 1521-4141
Institucionální podpora: RVO:68378050
Klíčová slova: Arthritis * B cells * B-cell depletion * B-cell inhibition * CD79b * Humoral immune response
Kód oboru RIV: EB - Genetika a molekulární biologie
Impakt faktor: 4.179, rok: 2015
Trvalý link: http://hdl.handle.net/11104/0245232
Bruhl, H. - Cihak, J. - Talke, Y. - Rodriguez-Gomez, M. - Hermann, F. - Goebel, N. - Renner, K. - Plachý, Jiří - Stangassinger, M. - Archemann, S. - Nimmerjahn, F. - Mack, M.
B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis.
European Journal of Immunology. Roč. 45, č. 3 (2015), s. 705-715. ISSN 0014-2980. E-ISSN 1521-4141
Institucionální podpora: RVO:68378050
Klíčová slova: Arthritis * B cells * B-cell depletion * B-cell inhibition * CD79b * Humoral immune response
Kód oboru RIV: EB - Genetika a molekulární biologie
Impakt faktor: 4.179, rok: 2015
Trvalý link: http://hdl.handle.net/11104/0245232